Özdemir, B. C., Moehler, M., Syn, N. L., Tai, B., & Wagner, A. D. (2019). Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immune checkpoint inhibitors for first‐ or second‐line treatment of advanced gastric and gastro‐esophageal junction cancer. Cochrane Database Syst Rev.
Chicago Style CitationÖzdemir, Berna C., Markus Moehler, Nicholas LX Syn, Bee‐Choo Tai, i Anna Dorothea Wagner. "Immune Checkpoint Inhibitors Plus Chemotherapy Versus Chemotherapy or Immune Checkpoint Inhibitors for First‐ or Second‐line Treatment of Advanced Gastric and Gastro‐esophageal Junction Cancer." Cochrane Database Syst Rev 2019.
Cita MLAÖzdemir, Berna C., et al. "Immune Checkpoint Inhibitors Plus Chemotherapy Versus Chemotherapy or Immune Checkpoint Inhibitors for First‐ or Second‐line Treatment of Advanced Gastric and Gastro‐esophageal Junction Cancer." Cochrane Database Syst Rev 2019.